MAPT and Alzheimer disease: MiR-132 is also reduced in AD, being associated with increased expression of inositol 1,4,5-triphosphate 3 kinase B (ITPKB) and augmented Tau phosphorylation in the hippocampus of mice, favoring disease progression and cognitive dysfunction [180].